30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Becton Dickinson and Co (BDX)

Track

Over the last 90 days, Becton Dickinson and Co. has seen net insider selling totaling approximately $426,806. The majority of transactions were sales, with no reported insider purchases. Notably, executives have been net sellers, reflecting a trend of divestment among key personnel. The stock has experienced a 6.6% decline in the past 90 days.
Stock chart
Ticker: BDX Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
2 sales — total 200,000 USD
Sale 10 Jun 2026
Value US$3,529,532.93 | Price 397.59 | Shares 40,788
Sale 10 Jun 2026
Value US$2,725,549.29 | Price 188.39 | Shares 25,396
Proposed sale 10 Jun 2026
Value US$822,906.39 | Price 135.43 | Shares 42,117
Sale 1 Jun 2026
Value US$100,000.00 | Price 146.35 | Shares 1,000
Proposed sale 1 Jun 2026
Value US$100,000.00 | Price 147.12 | Shares 1,000
Sale 26 May 2026
Value US$11,051.25 | Price 147.35 | Shares 75
Proposed sale 26 May 2026
Value US$11,072.25 | Price 147.63 | Shares 75
Sale 27 Apr 2026
Value US$11,243.56 | Price 151.94 | Shares 74
Proposed sale 27 Apr 2026
Value US$11,258.36 | Price 152.14 | Shares 74
Planned sale 26 Mar 2026
Value US$11,762.25 | Price 156.83 | Shares 75
Proposed sale 26 Mar 2026
Value US$11,870.25 | Price 158.27 | Shares 75
Sale 26 Feb 2026
Value US$13,638.00 | Price 181.84 | Shares 75
Proposed sale 26 Feb 2026
Value US$13,572.00 | Price 180.96 | Shares 75
Proposed sale 20 Feb 2026
Value US$998,429.24 | Price 184.14 | Shares 5,422
Proposed sale 20 Feb 2026
Value US$2,079,070.15 | Price 183.91 | Shares 11,305
Sale 18 Feb 2026
Value US$174,027.33 | Price 182.61 | Shares 953
Proposed sale 18 Feb 2026
Value US$1,708,885.71 | Price 182.46 | Shares 9,366
Proposed sale 18 Feb 2026
Value US$174,027.33 | Price 182.61 | Shares 953
Sale 26 Jan 2026
Value US$15,204.75 | Price 202.73 | Shares 75
Proposed sale 26 Jan 2026
Value US$15,134.25 | Price 201.79 | Shares 75
Sale 15 Jan 2026
Value US$208,605.40 | Price 206.54 | Shares 1,010
Sale 15 Jan 2026
Value US$125,400.00 | Price 209.00 | Shares 600
Proposed sale 15 Jan 2026
Value US$333,946.20 | Price 207.42 | Shares 1,610
Proposed sale 26 Dec 2025
Value US$14,512.88 | Price 196.12 | Shares 74
Sale 26 Dec 2025
Value US$14,509.92 | Price 196.08 | Shares 74
Proposed sale 17 Dec 2025
Value US$123,529.31 | Price 196.39 | Shares 629
Sale 17 Dec 2025
Value US$123,302.87 | Price 196.03 | Shares 629
Sale 1 Dec 2025
Value US$14,502.00 | Price 193.36 | Shares 75
Proposed sale 1 Dec 2025
Value US$14,551.50 | Price 194.02 | Shares 75
Proposed sale 7 Nov 2025
Value US$38,317.88 | Price 176.58 | Shares 217
Sale 7 Nov 2025
Value US$38,317.86 | Price 176.58 | Shares 217
Sale 27 Oct 2025
Value US$10,602.57 | Price 186.01 | Shares 57
Proposed sale 27 Oct 2025
Value US$10,592.31 | Price 185.83 | Shares 57
Sale 26 Sep 2025
Value US$10,499.74 | Price 181.03 | Shares 58
Proposed sale 26 Sep 2025
Value US$10,474.22 | Price 180.59 | Shares 58
Sale 10 Sep 2025
Value US$171,937.50 | Price 187.50 | Shares 917
Proposed sale 10 Sep 2025
Value US$171,862.50 | Price 187.42 | Shares 917
Sale 22 Aug 2025
Value US$11,285.43 | Price 197.99 | Shares 57
Proposed sale 22 Aug 2025
Value US$11,207.91 | Price 196.63 | Shares 57
Buy 11 Aug 2025
Value US$1,005,742.50 | Price 191.57 | Shares 5,250
Proposed sale 8 Aug 2025
Value US$165,879.90 | Price 192.21 | Shares 863
Sale 8 Aug 2025
Value US$165,954.90 | Price 192.30 | Shares 863
Sale 18 Jul 2025
Value US$181.50 | Price 181.50 | Shares 1
Sale 18 Jul 2025
Value US$213,463.36 | Price 180.29 | Shares 1,184
Proposed sale 18 Jul 2025
Value US$214,366.50 | Price 180.90 | Shares 1,185
Proposed sale 2 Jun 2025
Value US$201,239.94 | Price 172.59 | Shares 1,166
Sale 2 Jun 2025
Value US$199,607.54 | Price 171.19 | Shares 1,166
Sale 9 Apr 2025
Value US$94,497.12 | Price 197.28 | Shares 479
Proposed sale 9 Apr 2025
Value US$96,197.57 | Price 200.83 | Shares 479
Sale 18 Mar 2025
Value US$105,570.00 | Price 230.00 | Shares 459
Proposed sale 18 Mar 2025
Value US$104,573.97 | Price 227.83 | Shares 459
Sale 12 Mar 2025
Value US$436,325.40 | Price 224.91 | Shares 1,940
Proposed sale 12 Mar 2025
Value US$436,344.80 | Price 224.92 | Shares 1,940
Proposed sale 12 Feb 2025
Value US$159,593.00 | Price 227.99 | Shares 700
Sale 12 Feb 2025
Value US$159,593.00 | Price 227.99 | Shares 700
Buy 10 Feb 2025
Value US$350,430.00 | Price 233.62 | Shares 1,500
Sale 21 Jan 2025
Value US$188,880.00 | Price 240.00 | Shares 787
Sale 21 Jan 2025
Value US$120,000.00 | Price 240.00 | Shares 500
Proposed sale 21 Jan 2025
Value US$186,818.06 | Price 237.38 | Shares 787
Proposed sale 21 Jan 2025
Value US$118,690.00 | Price 237.38 | Shares 500
Sale 17 Jan 2025
Value US$141,196.47 | Price 236.51 | Shares 597
Proposed sale 17 Jan 2025
Value US$141,071.10 | Price 236.30 | Shares 597
Sale 7 Jan 2025
Value US$185,180.00 | Price 235.00 | Shares 788
Proposed sale 7 Jan 2025
Value US$181,791.60 | Price 230.70 | Shares 788
Sale 19 Dec 2024
Value US$633,810.54 | Price 223.33 | Shares 2,838
Proposed sale 19 Dec 2024
Value US$635,967.42 | Price 224.09 | Shares 2,838
Sale 9 Dec 2024
Value US$139,741.14 | Price 219.03 | Shares 638
Proposed sale 9 Dec 2024
Value US$140,372.76 | Price 220.02 | Shares 638
Sale 6 Dec 2024
Value US$990,787.83 | Price 221.01 | Shares 4,483
Sale 6 Dec 2024
Value US$220,490.00 | Price 220.49 | Shares 1,000
Proposed sale 6 Dec 2024
Value US$996,301.92 | Price 222.24 | Shares 4,483
Proposed sale 6 Dec 2024
Value US$222,240.00 | Price 222.24 | Shares 1,000
Sale 5 Dec 2024
Value US$330,375.00 | Price 220.25 | Shares 1,500
Proposed sale 5 Dec 2024
Value US$332,145.00 | Price 221.43 | Shares 1,500
Proposed sale 16 Sep 2024
Value US$94,312.00 | Price 235.78 | Shares 400
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-11 2026-06-10 S Sale
3.1
Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

Officer
40,788 -5.5%
397.59
US$3,529,533 		40,788 -5.5% 397.59 US$3,529,533
2026-06-11 2026-06-10 S Sale
3.1
Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

Officer
25,396 -18.8%
188.39
US$2,725,549 		25,396 -18.8% 188.39 US$2,725,549
2026-06-10 2026-06-10 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
42,117
135.43
US$822,906 		42,117 135.43 US$822,906
2026-06-03 2026-06-01 S Sale
Polen Thomas E Jr

Chairman, CEO and President

Executive Director
1,000 -2.4%
146.35
US$100,000 		1,000 -2.4% 146.35 US$100,000
2026-06-01 2026-06-01 PrS Proposed sale
THOMAS POLEN

Officer

Officer
1,000
147.12
US$100,000 		1,000 147.12 US$100,000
2026-05-27 2026-05-26 S Sale
2.7
Feld Michael

EVP, Chief Revenue Officer

Officer
75 -0.4%
147.35
US$11,051 		75 -0.4% 147.35 US$11,051
2026-05-26 2026-05-26 PrS Proposed sale
2.7
MICHAEL FELD

Officer

Officer
75
147.63
US$11,072 		75 147.63 US$11,072
2026-04-28 2026-04-27 S Sale
2.7
Feld Michael

EVP, Chief Revenue Officer

Officer
74 -0.3%
151.94
US$11,244 		74 -0.3% 151.94 US$11,244
2026-04-27 2026-04-27 PrS Proposed sale
2.7
MICHAEL FELD

Officer

Officer
74
152.14
US$11,258 		74 152.14 US$11,258
2026-03-27 2026-03-26 PlS Planned sale
2.7
Feld Michael

EVP, Chief Revenue Officer

Officer
75 -0.4%
156.83
US$11,762 		75 -0.4% 156.83 US$11,762
2026-03-26 2026-03-26 PrS Proposed sale
2.7
MICHAEL FELD

Officer

Officer
75
158.27
US$11,870 		75 158.27 US$11,870
2026-02-27 2026-02-26 S Sale
2.7
Feld Michael

EVP, Chief Revenue Officer

Officer
75 -0.4%
181.84
US$13,638 		75 -0.4% 181.84 US$13,638
2026-02-26 2026-02-26 PrS Proposed sale
2.7
MICHAEL FELD

Officer

Officer
75
180.96
US$13,572 		75 180.96 US$13,572
2026-02-20 2026-02-20 PrS Proposed sale
2.4
DAVID MICHEL SHAN

Former Officer

Officer
5,422
184.14
US$998,429 		5,422 184.14 US$998,429
2026-02-20 2026-02-20 PrS Proposed sale
CHRISTOPHER DELOREFICE

Former Officer

Officer
11,305
183.91
US$2,079,070 		11,305 183.91 US$2,079,070
2026-02-18 2026-02-18 S Sale
3.1
SCOTT BERTRAM L
Non-Executive Director
953 -2.5%
182.61
US$174,027 		953 -2.5% 182.61 US$174,027
2026-02-18 2026-02-18 PrS Proposed sale
CHRISTOPHER DELOREFICE

Former Officer

Officer
9,366
182.46
US$1,708,886 		9,366 182.46 US$1,708,886
2026-02-18 2026-02-18 PrS Proposed sale
3.1
BERTRAM SCOTT

Director

Non-Executive Director
953
182.61
US$174,027 		953 182.61 US$174,027
2026-01-28 2026-01-26 S Sale
2.7
Feld Michael

EVP, CRO & Pres. Life Sciences

Officer
75 -0.5%
202.73
US$15,205 		75 -0.5% 202.73 US$15,205
2026-01-26 2026-01-26 PrS Proposed sale
2.7
MICHAEL FELD

Officer

Officer
75
201.79
US$15,134 		75 201.79 US$15,134
2026-01-16 2026-01-15 S Sale
3.1
Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

Officer
1,010 -7.7%
206.54
US$208,605 		1,010 -7.7% 206.54 US$208,605
2026-01-16 2026-01-15 S Sale
3.1
Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

Officer
600 -4.4%
209.00
US$125,400 		600 -4.4% 209.00 US$125,400
2026-01-15 2026-01-15 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
1,610
207.42
US$333,946 		1,610 207.42 US$333,946
2025-12-29 2025-12-26 PrS Proposed sale
2.7
MICHAEL FELD

Officer

Officer
74
196.12
US$14,513 		74 196.12 US$14,513
2025-12-29 2025-12-26 S Sale
2.7
Feld Michael

EVP, CRO & Pres. Life Sciences

Officer
74 -0.4%
196.08
US$14,510 		74 -0.4% 196.08 US$14,510
2025-12-17 2025-12-17 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
629
196.39
US$123,529 		629 196.39 US$123,529
2025-12-17 2025-12-17 S Sale
3.1
Garrison Michael David

EVP & Pres Med.Essntl&BioPharm

Officer
629 -4.6%
196.03
US$123,303 		629 -4.6% 196.03 US$123,303
2025-12-02 2025-12-01 S Sale
2.7
Feld Michael

EVP, CRO & Pres. Life Sciences

Officer
75 -0.5%
193.36
US$14,502 		75 -0.5% 193.36 US$14,502
2025-12-01 2025-12-01 PrS Proposed sale
2.7
MICHAEL FELD

Officer

Officer
75
194.02
US$14,552 		75 194.02 US$14,552
2025-11-07 2025-11-07 PrS Proposed sale
3.1
BERTRAM SCOTT

Officer

Officer
217
176.58
US$38,318 		217 176.58 US$38,318
2025-11-07 2025-11-07 S Sale
3.1
SCOTT BERTRAM L
Non-Executive Director
217 -0.6%
176.58
US$38,318 		217 -0.6% 176.58 US$38,318
2025-10-28 2025-10-27 S Sale
2.7
Feld Michael

EVP & President, Life Sciences

Officer
57 -0.7%
186.01
US$10,603 		57 -0.7% 186.01 US$10,603
2025-10-27 2025-10-27 PrS Proposed sale
2.7
MICHAEL FELD

Officer

Officer
57
185.83
US$10,592 		57 185.83 US$10,592
2025-09-29 2025-09-26 S Sale
2.7
Feld Michael

EVP & President, Life Sciences

Officer
58 -0.7%
181.03
US$10,500 		58 -0.7% 181.03 US$10,500
2025-09-26 2025-09-26 PrS Proposed sale
2.7
MICHAEL FELD

Officer

Officer
58
180.59
US$10,474 		58 180.59 US$10,474
2025-09-11 2025-09-10 S Sale
3.5
Fraser Claire
Non-Executive Director
917 -4.0%
187.50
US$171,938 		917 -4.0% 187.50 US$171,938
2025-09-10 2025-09-10 PrS Proposed sale
3.5
Fraser Claire

Director

Non-Executive Director
917
187.42
US$171,862 		917 187.42 US$171,862
2025-08-26 2025-08-22 S Sale
2.7
Feld Michael

EVP & President, Life Sciences

Officer
57 -0.7%
197.99
US$11,285 		57 -0.7% 197.99 US$11,285
2025-08-22 2025-08-22 PrS Proposed sale
2.7
MICHAEL FELD

Officer

Officer
57
196.63
US$11,208 		57 196.63 US$11,208
2025-08-11 2025-08-11 B Purchase
3.5
HAYES GREGORY
Non-Executive Director
5,250 +659.5%
191.57
US$1,005,742 		5,250 +659.5% 191.57 US$1,005,742
2025-08-08 2025-08-08 PrS Proposed sale
3.5
Fraser Claire

Director

Non-Executive Director
863
192.21
US$165,880 		863 192.21 US$165,880
2025-08-08 2025-08-08 S Sale
3.5
Fraser Claire
Non-Executive Director
863 -3.6%
192.30
US$165,955 		863 -3.6% 192.30 US$165,955
2025-07-22 2025-07-18 S Sale
3.1
Garrison Michael David

EVP & President, Medical

Officer
1 -0.0%
181.50
US$182 		1 -0.0% 181.50 US$182
2025-07-22 2025-07-18 S Sale
3.1
Garrison Michael David

EVP & President, Medical

Officer
1,184 -19.5%
180.29
US$213,463 		1,184 -19.5% 180.29 US$213,463
2025-07-18 2025-07-18 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
1,185
180.90
US$214,366 		1,185 180.90 US$214,366
2025-06-02 2025-06-02 PrS Proposed sale
2.4
DAVID SHAN

Officer

Officer
1,166
172.59
US$201,240 		1,166 172.59 US$201,240
2025-06-02 2025-06-02 S Sale
2.4
Shan David

EVP and Chief ISC Officer

Officer
1,166 -20.3%
171.19
US$199,608 		1,166 -20.3% 171.19 US$199,608
2025-04-10 2025-04-09 S Sale
3.1
Garrison Michael David

EVP & President, Medical

Officer
479 -8.9%
197.28
US$94,497 		479 -8.9% 197.28 US$94,497
2025-04-09 2025-04-09 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
479
200.83
US$96,198 		479 200.83 US$96,198
2025-03-19 2025-03-18 S Sale
3.2
Byrd Richard

EVP & President Interventional

Officer
459 -6.2%
230.00
US$105,570 		459 -6.2% 230.00 US$105,570
2025-03-18 2025-03-18 PrS Proposed sale
3.2
RICHARD BYRD

Officer

Officer
459
227.83
US$104,574 		459 227.83 US$104,574
2025-03-13 2025-03-12 S Sale
3.2
Byrd Richard

EVP & President Interventional

Officer
1,940 -20.7%
224.91
US$436,325 		1,940 -20.7% 224.91 US$436,325
2025-03-12 2025-03-12 PrS Proposed sale
3.2
RICHARD BYRD

Officer

Officer
1,940
224.92
US$436,345 		1,940 224.92 US$436,345
2025-02-12 2025-02-12 PrS Proposed sale
3.1
BERTRAM SCOTT

Director

Non-Executive Director
700
227.99
US$159,593 		700 227.99 US$159,593
2025-02-12 2025-02-12 S Sale
3.1
SCOTT BERTRAM L
Non-Executive Director
700 -1.9%
227.99
US$159,593 		700 -1.9% 227.99 US$159,593
2025-02-10 2025-02-10 B Purchase
2.9
Henderson Jeffrey William
Non-Executive Director
1,500 +23.0%
233.62
US$350,430 		1,500 +23.0% 233.62 US$350,430
2025-01-22 2025-01-21 S Sale
3.1
Neal Shana Carol

EVP and Chief People Officer

Officer
787 -4.9%
240.00
US$188,880 		787 -4.9% 240.00 US$188,880
2025-01-22 2025-01-21 S Sale
2.4
Shan David

EVP and Chief ISC Officer

Officer
500 -8.0%
240.00
US$120,000 		500 -8.0% 240.00 US$120,000
2025-01-21 2025-01-21 PrS Proposed sale
3.1
SHANA NEAL

Officer

Officer
787
237.38
US$186,818 		787 237.38 US$186,818
2025-01-21 2025-01-21 PrS Proposed sale
2.4
DAVID SHAN

Officer

Officer
500
237.38
US$118,690 		500 237.38 US$118,690
2025-01-21 2025-01-17 S Sale
3.1
Garrison Michael David

EVP & President, Medical

Officer
597 -9.7%
236.51
US$141,196 		597 -9.7% 236.51 US$141,196
2025-01-17 2025-01-17 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
597
236.30
US$141,071 		597 236.30 US$141,071
2025-01-10 2025-01-07 S Sale
3.1
Neal Shana Carol

EVP and Chief People Officer

Officer
788 -4.6%
235.00
US$185,180 		788 -4.6% 235.00 US$185,180
2025-01-07 2025-01-07 PrS Proposed sale
3.1
SHANA NEAL

Officer

Officer
788
230.70
US$181,792 		788 230.70 US$181,792
2024-12-20 2024-12-19 S Sale
3.1
Garrison Michael David

EVP & President, Medical

Officer
2,838 -31.6%
223.33
US$633,811 		2,838 -31.6% 223.33 US$633,811
2024-12-19 2024-12-19 PrS Proposed sale
3.1
MICHAEL GARRISON

Officer

Officer
2,838
224.09
US$635,967 		2,838 224.09 US$635,967
2024-12-10 2024-12-09 S Sale
2.8
Goette Roland

EVP and President, EMEA

Officer
638 -4.3%
219.03
US$139,741 		638 -4.3% 219.03 US$139,741
2024-12-09 2024-12-09 PrS Proposed sale
2.8
ROLAND GOETTE

Officer

Officer
638
220.02
US$140,373 		638 220.02 US$140,373
2024-12-10 2024-12-06 S Sale
2.8
Goette Roland

EVP and President, EMEA

Officer
4,483 -15.6%
221.01
US$990,788 		4,483 -15.6% 221.01 US$990,788
2024-12-10 2024-12-06 S Sale
3.1
Neal Shana Carol

EVP and Chief People Officer

Officer
1,000 -5.6%
220.49
US$220,490 		1,000 -5.6% 220.49 US$220,490
2024-12-06 2024-12-06 PrS Proposed sale
2.8
ROLAND GOETTE

Officer

Officer
4,483
222.24
US$996,302 		4,483 222.24 US$996,302
2024-12-06 2024-12-06 PrS Proposed sale
3.1
SHANA NEAL

Officer

Officer
1,000
222.24
US$222,240 		1,000 222.24 US$222,240
2024-12-06 2024-12-05 S Sale
2.4
Shan David

EVP and Chief ISC Officer

Officer
1,500 -19.3%
220.25
US$330,375 		1,500 -19.3% 220.25 US$330,375
2024-12-05 2024-12-05 PrS Proposed sale
2.4
DAVID SHAN

Officer

Officer
1,500
221.43
US$332,145 		1,500 221.43 US$332,145
2024-09-16 2024-09-16 PrS Proposed sale
2.1
BURZIK CATHERINE M

Director

Non-Executive Director
400
235.78
US$94,312 		400 235.78 US$94,312
Explore more

More insider trading research around Becton Dickinson and Co

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America
Insider trades in S&P 500